PRSS50 and neoplasm: On the other hand, in TSP50-overexpressing cells, PKM2 K433R transfection group demonstrated a smaller tumor size (vs. PKM2 WT group as a control), accompanied by a dramatically reduced tumor weight (Fig. 8L–N).